A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa
Condition: Acne Inversa Interventions: Drug: PF-06650833; Drug: PF-06700841; Drug: PF-06826647; Drug: Placebo Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials